Resolution of hypertension symptoms following cerebrospinal fluid leak with acetazolamide: a case report

Both patients reported tinnitus and visual changes closely aligned with headache symptoms. They were treated for ICH using a 4 weeks regimen of acetazolamide, followed by a tapering period of 4 weeks. With the initiation of acetazolamide, both patients experienced near-complete relief from their symptoms and were successfully weaned off. It is hypothesized that both individuals may have developed an overproduction of CSF following their prior leaks, leading to ICH, which effectively mitigated Acetazolamide's established role in reducing intracranial pressure.